Adjuvant dabrafenib plus trametinib (DT) treatment completion in patients with resected melanoma in Spain: A retrospective observational study (GEM 1901-DESCRIBE-AD)

Por: Manzano, JL, Martin-Liberal, J, Fernandez-Morales, LA, Benitez, G, Medina, J, Quindos, M, Garcia-Castano, A, Fernandez, O, Simo, RV, Majem, M, Hernandez, LB, de Miguel, PA, Campos, B, Espinosa, E, Cerrolaza, JAM, Gil-Arnaiz, I, Lorente, D, Martinez-Fernandez, A, Martin-Sanchez, E and Cerezuela-Fuentes, P

---

Publicada: 1 sep 2021 Ahead of Print: 1 sep 2021

---

---

Filiaciones:
:
 Hosp Badalona Germans Trias & Pujol, ICO Badalona, Med Oncol, Barcelona, Spain

Martin-Liberal, J:
 Catalan Inst Oncol ICO LHosp, Med Oncol, Barcelona, Spain

Fernandez-Morales, LA:
 Corporacio Sanit Parc Tauli, Med Oncol, Barcelona, Spain

Benitez, G:
 Hosp Univ Insular Gran Canaria, Med Oncol, Las Palmas Gran Canaria, Spain

Medina, J:
 Hosp Virgen La Salud, Med Oncol, Toledo, Spain

Quindos, M:
 Complejo Hosp Univ A Coruna, Med Oncol, La Coruna, Spain

Garcia-Castano, A:
 Hosp Univ Marques Valdecilla, Med Oncol, Santander, Spain

Fernandez, O:
 Complejo Hosp Univ Ourense, Med Oncol, Orense, Spain

Simo, RV:
 Hosp Arquitecto Marcide, Med Oncol, Ferrol, Spain

Majem, M:
 Hosp Santa Creu & Sant Pau, Med Oncol, Barcelona, Spain

Hernandez, LB:
 Complejo Asistencial Univ Salamanca, Med Oncol, Salamanca, Spain

de Miguel, PA:
 Hosp San Pedro Alcantara, Med Oncol, Caceres, Spain

Campos, B:
 Hosp Univ Lucus Augusti Lugo, Med Oncol, Lugo, Spain

Espinosa, E:
 Hosp Univ La Paz, Med Oncol, Madrid, Spain

Cerrolaza, JAM:
 Hosp Gen Univ Morales Meseguer, Med Oncol, Murcia, Spain

Gil-Arnaiz, I:
 Hosp Reina Sofia Tudela, Med Oncol, Navarra, Spain

Lorente, D:
 Hosp Prov Castellon, Med Oncol, Castellon De La Plana, Spain

Martinez-Fernandez, A:
 Novartis Farmaceut SA, Solid Tumors Med Dept, Barcelona, Spain

Martin-Sanchez, E:
 Novartis Farmaceut SA, Market Access Dept, Barcelona, Spain

Cerezuela-Fuentes, P:
 Hosp Univ Virgen Arrixaca, Med Oncol, Murcia, Spain